Post by BioDuro

🎞️𝗨𝗽𝗰𝗼𝗺𝗶𝗻𝗴 𝗪𝗲𝗯𝗶𝗻𝗮𝗿: In 2001, Craig Crews and his team at Yale introduced PROTACs, reshaping small-molecule drug discovery. Today, that concept has evolved into RIPTACs (Regulated Induced Proximity Targeting Chimera), shifting the focus from protein degradation to functional sequestration. In preclinical PROTAC and RIPTAC programs, our work spans the full discovery workflow. Join us on 𝗔𝗽𝗿𝗶𝗹 𝟯𝟬 to explore how chemistry and in vitro biology come together in these programs, from rapid synthesis of heterobifunctional compounds and isomer separation to in vitro profiling that supports compound selection and optimization. Together, these approaches help enable faster, more informed decision-making and support more efficient progression of early discovery programs. Secure your spot today: https://lnkd.in/e6FrNecd #PROATC #RIPTAC #DrugDiscovery #Webinar